Food Noise, Willpower and Retatrutide! Talking with Dr. Ania Jastreboff

madman

Super Moderator
Summary
Yale's Dr. Ania Jastreboff on food noise, why obesity is not a willpower failure, and how retatrutide differs from semaglutide and tirzepatide.

The Downsized sits down with Dr. Ania Jastreboff, Yale professor, endocrinologist, obesity medicine physician-scientist, director of the Yale Obesity Research Center, and one of the leading researchers studying the next generation of obesity medications.

In the first half of this special two-part conversation, Christopher and Laraine Durham talk with Dr. Jastreboff about what obesity science is teaching us about weight, hunger, food noise, biology, and why obesity is not a failure of willpower.


They also dive into retatrutide, the highly anticipated triple-hormone receptor agonist targeting GLP-1, GIP, and glucagon. Dr. Jastreboff discusses the TRIUMPH-1 trial and explains why researchers are interested in much more than weight loss, including the potential effects of glucagon activity on liver fat and metabolic health.




The conversation explores:

• How retatrutide differs from semaglutide and tirzepatide

• Why the next generation of obesity medications will go far beyond GLP-1s

• The role of amylin drugs such as cagrilintide and combinations such as CagriSema

• Why obesity may eventually require many different classes of medication

• Dr. Jastreboff’s “enough point” theory and how the brain regulates body fat

• Why the modern environment can push the body toward storing more fat

• Why biology drives far more of our eating behavior than most people realize

• What GLP-1 medications have taught researchers about food noise

• Why hunger returning does not necessarily mean a medication has stopped working

• What happens when patients reach a weight-loss plateau

• How to think about maintenance and finding the right weight for your body

• Why BMI and the number on the scale cannot tell the entire story

•
Why treating obesity before diabetes, cardiovascular disease, sleep apnea, or other complications develop matters
 

ExcelMale Newsletter Signup

Beyond Testosterone Podcast

Online statistics

Members online
1
Guests online
841
Total visitors
842

Latest posts

Back
Top